Entera Health launches EnteraGam
CARY, N.C. — Entera Health has launched a new prescription medical food product for patients with intestinal disorders, the company said.
The drug maker announced the availability of EnteraGam (serum-derived bovine immunoglobulin protein isolate, SBI) for patients with chronic loose or frequent stools due to irritable bowel syndrome or HIV. The drug is meant to treat patients who have limited or impaired ability to ingest, digest, absorb or metabolize ordinary foodstuffs or certain nutrients.
The company is offering a savings program allowing insured patients to pay as little as $25 for their prescriptions. The program will be available in more than 40,000 pharmacies, the company said.
FlavoRx, RxNT integrate medicine flavoring with e-prescribing, electronic health record applications
COLUMBIA, Md. — RxNT’s e-prescribing and electronic health record systems will incorporate taste options recommended by FlavoRx for liquid medications given to children in order to promote medication adherence, the two companies said.
In a recently announced deal, the companies said they would make enhancing the taste of medicine a seamless option for pediatric prescriptions and their patients. Prescribers can use RxNT’s software to designate a child’s preferred medication flavor directly on the electronic prescription, sending it to the pharmacy and facilitating the custom-flavoring process. Studies have indicated that bad-tasting medications can be a barrier to adherence among children.
"Pediatricians, nurse practitioners and physician’s assistants know first-hand the importance of taste when it comes to pediatric adherence," FlavoRx CEO Stuart Amos said. "The FlavoRx partnership with RxNT will go a long way toward improving adherence and outcomes for patients whose doctors, nurse practitioners or physician’s assistants use the RxNT eRx or RxNT EHR systems."
Canadian article explores benefits, implications of expanding pharmacists’ practice scope
NEW YORK — A new article published by researchers in Canada explains how expanding the kinds of services pharmacists can offer could improve patient care, but also have various implications for physicians.
The article, published in the the journal of the Canadian Medical Association, CMAJ (subscription required), and reported by HealthDay News, came from University of Montreal researcher Cara Tannenbaum and the University of Alberta’s Ross Tsuyuki.
In it, the researchers noted that pharmacists in Canada can renew, refuse to fill, adjust, initiate or substitute prescriptions, as well as order and interpret lab tests and administer injections and vaccines. While this could improve care for patients, it could also mean ethical, legal, financial and professional implications for physicians, and the authors advocated effective communication to ensure patient safety.